Page last updated: 2024-08-21

xanthinol niacinate and Apolipoprotein B-100, Familial Defective

xanthinol niacinate has been researched along with Apolipoprotein B-100, Familial Defective in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ditschuneit, H; Hutt, V; Klör, HU; Wechsler, JG	2
Haacke, H; Mäder, C; Parwaresch, MR	1
Fears, R; Ferres, H; Haacke, H; Mäder, C; Parwaresch, MR	1

Trials

1 trial(s) available for xanthinol niacinate and Apolipoprotein B-100, Familial Defective

Article	Year
Decrease in LDL and increase in HDL concentrations in type II hyperlipoproteinaemic patients on low-dose combination therapy of cholestyramine and Complamin. Atherosclerosis, 1988, Volume: 69, Issue:2-3 Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cholestyramine Resin; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hyperlipoproteinemia Type II; Lipoproteins, VLDL; Male; Middle Aged; Theophylline; Xanthinol Niacinate	1988

Article

Year

Decrease in LDL and increase in HDL concentrations in type II hyperlipoproteinaemic patients on low-dose combination therapy of cholestyramine and Complamin.

Atherosclerosis, 1988, Volume: 69, Issue:2-3

Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cholestyramine Resin; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hyperlipoproteinemia Type II; Lipoproteins, VLDL; Male; Middle Aged; Theophylline; Xanthinol Niacinate

1988

Other Studies

3 other study(ies) available for xanthinol niacinate and Apolipoprotein B-100, Familial Defective

Article	Year
Lipids and lipoproteins in hyperlipidemia type IIa during treatment with different lipid lowering drugs. Artery, 1980, Volume: 8, Issue:6 Topics: Adolescent; Bezafibrate; Clofibrate; Clofibric Acid; Female; Humans; Hyperlipoproteinemia Type II; Inositol; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Male; Nicotinic Acids; Nicotinyl Alcohol; Xanthinol Niacinate	1980
Serum profile of non-esterified fatty acids (NEFA) in patients with hyperlipoproteinemia under xantinol--nicotinate (XN) medication. Atherosclerosis, 1980, Volume: 37, Issue:1 Topics: Adolescent; Adult; Aged; Fatty Acids, Nonesterified; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Lipids; Middle Aged; Theophylline; Xanthinol Niacinate	1980
Changes in lipids and lipoproteins in patients with hyperlipidemia type IIb, IV and V treated with different lipid lowering drugs. Artery, 1980, Volume: 8, Issue:2 Topics: Anticholesteremic Agents; Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Inositol; Lipoproteins; Nicotinic Acids; Xanthinol Niacinate	1980